Cargando…
Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib
Autores principales: | Pinard, Camille, Mignard, Claire, Samain, Agnès, Duval-Modeste, Anne-Bénédicte, Joly, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728437/ https://www.ncbi.nlm.nih.gov/pubmed/29296640 http://dx.doi.org/10.1016/j.jdcr.2017.06.027 |
Ejemplares similares
-
Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!
por: Luherne, Camille, et al.
Publicado: (2019) -
Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
por: Young, Peter A., et al.
Publicado: (2021) -
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
por: Maximova, Natalia, et al.
Publicado: (2020) -
Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS)
por: Gill, Shaman, et al.
Publicado: (2013) -
COVID-19 : adhésion à la vaccination chez des patients immunodéprimés de dermatologie
por: Lafon, Audrey, et al.
Publicado: (2021)